Putnam Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $913M | Buy |
1,719,355
+381,542
| +29% | +$185M | 1.21% | 18 |
|
|
2023
Q3 | $677M | Buy |
1,337,813
+1,974
| +0.1% | +$1.05M | 1.03% | 21 |
|
|
2023
Q2 | $697M | Buy |
1,335,839
+46,507
| +4% | +$25.1M | 1.03% | 21 |
|
|
2023
Q1 | $743M | Buy |
1,289,332
+121,686
| +10% | +$68.6M | 1.19% | 14 |
|
|
2022
Q4 | $643M | Sell |
1,167,646
-50,137
| -4% | -$26.6M | 1.12% | 20 |
|
|
2022
Q3 | $618M | Sell |
1,217,783
-28,770
| -2% | -$16.1M | 1.17% | 17 |
|
|
2022
Q2 | $677M | Sell |
1,246,553
-8,211
| -0.7% | -$4.52M | 1.21% | 15 |
|
|
2022
Q1 | $741M | Buy |
1,254,764
+15,461
| +1% | +$8.88M | 1.12% | 16 |
|
|
2021
Q4 | $827M | Buy |
1,239,303
+167,182
| +16% | +$104M | 1.18% | 14 |
|
|
2021
Q3 | $613M | Sell |
1,072,121
-37,195
| -3% | -$20.4M | 0.95% | 24 |
|
|
2021
Q2 | $560M | Buy |
1,109,316
+670,372
| +153% | +$316M | 0.87% | 24 |
|
|
2021
Q1 | $200M | Sell |
438,944
-45,572
| -9% | -$21.8M | 0.33% | 85 |
|
|
2020
Q4 | $226M | Sell |
484,516
-168,488
| -26% | -$79M | 0.4% | 74 |
|
|
2020
Q3 | $288M | Sell |
653,004
-22,641
| -3% | -$9.35M | 0.57% | 48 |
|
|
2020
Q2 | $245M | Sell |
675,645
-38,881
| -5% | -$13M | 0.52% | 52 |
|
|
2020
Q1 | $203M | Buy |
714,526
+128,982
| +22% | +$40.7M | 0.53% | 49 |
|
|
2019
Q4 | $190M | Buy |
585,544
+103,689
| +22% | +$31.4M | 0.39% | 72 |
|
|
2019
Q3 | $140M | Sell |
481,855
-238,940
| -33% | -$68.4M | 0.31% | 96 |
|
|
2019
Q2 | $212M | Buy |
720,795
+694,545
| +2,646% | +$191M | 0.47% | 59 |
|
|
2019
Q1 | $7.19M | Buy |
26,250
+18,842
| +254% | +$4.69M | 0.02% | 412 |
|
|
2018
Q4 | $1.66M | Sell |
7,408
-2,383
| -24% | -$559K | ﹤0.01% | 667 |
|
|
2018
Q3 | $2.39M | Sell |
9,791
-151
| -2% | -$34.7K | 0.01% | 733 |
|
|
2018
Q2 | $2.06M | Sell |
9,942
-801
| -7% | -$170K | ﹤0.01% | 714 |
|
|
2018
Q1 | $2.22M | Sell |
10,743
-558
| -5% | -$117K | 0.01% | 696 |
|
|
2017
Q4 | $2.15M | Sell |
11,301
-1,303
| -10% | -$250K | ﹤0.01% | 739 |
|
|
2017
Q3 | $2.38M | Sell |
12,604
-3,835
| -23% | -$695K | 0.01% | 713 |
|
|
2017
Q2 | $2.87M | Sell |
16,439
-118,233
| -88% | -$19.9M | 0.01% | 664 |
|
|
2017
Q1 | $20.7M | Sell |
134,672
-4,084
| -3% | -$624K | 0.05% | 284 |
|
|
2016
Q4 | $19.6M | Sell |
138,756
-6,878
| -5% | -$1.01M | 0.05% | 285 |
|
|
2016
Q3 | $23.2M | Sell |
145,634
-137,334
| -49% | -$21.2M | 0.06% | 258 |
|
|
2016
Q2 | $41.8M | Sell |
282,968
-91
| -0% | -$13.4K | 0.1% | 193 |
|
|
2016
Q1 | $40.1M | Buy |
283,059
+84,958
| +43% | +$11.4M | 0.1% | 195 |
|
|
2015
Q4 | $28.1M | Hold |
198,101
| – | – | 0.06% | 258 |
|
|
2015
Q3 | $24.2M | Sell |
198,101
-300
| -0.2% | -$39.1K | 0.05% | 276 |
|
|
2015
Q2 | $25.7M | Sell |
198,401
-61,707
| -24% | -$8.04M | 0.05% | 294 |
|
|
2015
Q1 | $34.9M | Sell |
260,108
-406,065
| -61% | -$52.3M | 0.07% | 249 |
|
|
2014
Q4 | $83.5M | Buy |
666,173
+12,287
| +2% | +$1.49M | 0.17% | 131 |
|
|
2014
Q3 | $79.6M | Sell |
653,886
-669,820
| -51% | -$81.4M | 0.17% | 134 |
|
|
2014
Q2 | $156M | Sell |
1,323,706
-276,921
| -17% | -$32.6M | 0.34% | 72 |
|
|
2014
Q1 | $192M | Sell |
1,600,627
-55,617
| -3% | -$6.61M | 0.44% | 63 |
|
|
2013
Q4 | $184M | Sell |
1,656,244
-112,284
| -6% | -$11.2M | 0.44% | 51 |
|
|
2013
Q3 | $163M | Sell |
1,768,528
-12,760
| -0.7% | -$1.15M | 0.44% | 61 |
|
|
2013
Q2 | $151M | Buy |
+1,781,288
| New | +$148M | 0.44% | 55 |
|
Other funds holding TMO
Putnam Investments's TMO Position: Q4 2023 in Review
Putnam Investments increased its Thermo Fisher Scientific (TMO) stake by 29% in Q4 2023, buying an estimated $185M and bringing the position to 1,719,355 shares worth $913M. The position accounts for 1.21% of the portfolio, ranked #18.
Putnam Investments first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.
- Putnam Investments held 1,719,355 shares of Thermo Fisher Scientific worth $913M as of Q4 2023.
- Putnam Investments bought 381,542 Thermo Fisher Scientific shares in Q4 2023, an estimated $185M.
- Thermo Fisher Scientific made up 1.21% of Putnam Investments's portfolio in Q4 2023, its #18 holding.
- Putnam Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
- 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.